ACTSI Newsletter
|
Trouble viewing this email? Click here
to view on the web.
| |
| |  | 
ACTSI Weekly eRoundup
August 25, 2017
|
| |
| | | | | ACTSI's biostatistics program developed an optimal three-stage group sequential design for monitoring the safety of the clinical trial Bela 8 Week Dosing. The trial is examining immunosuppression therapy in post-transplant kidney recipients and is led by I. Raul Badell, MD, assistant professor of surgery, Division of Transplantation, Emory University School of Medicine, in the Emory Transplant Center.
The immunosuppressive drug called belatacept ... | | | | Read More | | |
|
| |
| | | | As competition for research funding opportunities increases, the ASPIRE program underscores Pfizer's commitment to supporting exceptional investigators with an interest in advancing their academic research careers in Endocrinology. | | | | Read More | | |
| |
| | | | Solid research is the underlying driving force to crystallize fearless creativity and innovation. Sony is excited to collaborate with academic partners to facilitate exploration of new and promising research. The awards provide an opportunity for university faculty and Sony to conduct this type of collaborative, focused research. The award provides up to $150K in funds, and may be renewed for subsequent year(s). | | | | Read More | | |
| |
| | | | The purpose of this initiative is to encourage preclinical and clinical research and secondary data analysis on symptom cluster characterization that has potential to inform treatment and interventions that improve functional outcomes and quality of life in patients with chronic conditions. | | | | Read More | | |
| |
| | | | The overarching goals of this FOA are to develop tools and technologies to control and reprogram biological systems, to increase the fundamental understanding of synthetic biology concepts as they relate to human health, to gain fundamental biological knowledge, to apply synthetic biology approaches for the development of biomedical technologies, and to encourage the participation of early stage investigators in synthetic biology. | | | | Read More | | |
| |
| | | | Cutting-edge research in the biomedical, behavioral, clinical sciences and technologies requires new ideas, techniques, and points of view. Such ideas may differ substantially from current thinking or practice. The NIBIB seeks to foster these new scientific bioengineering and imaging ideas, model systems, tools, agents, targets, and technologies through the Exploratory/Developmental Research Grant Program. P41 also available. | | | | Read More | | |
| |
| | | | The P30 mechanism is used to support planning for new programs, expansion or modification of existing resources, and studies to explore various approaches to the development of interdisciplinary programs that offer potential solutions to problems of special significance to the mission of the NIH. The purpose of this program is to support NINR P30 Centers of Excellence to enhance interdisciplinary, biobehavioral research for scientists conducting research in multiple complex chronic conditions in human adult populations.
| | | | Read More | | |
| |
| | | | The award was established to allow investigators from a variety of disciplines to initiate new projects relevant to Eosinophilic Disorders, excluding asthma, rhinitis, and eczema. Successful applications will focus on the development of new ideas which are likely to lead to future external funding. | | | | Read More | | |
| |
| | | | Misconduct: We¿re Not Recruiting Enough Participants | | | | Read More | | |
| |
| | | | A free weekly walk-in statistical consulting clinic for faculty, staff, and students providing 20-minute immediate assistance for basic statistics questions, without scheduling a formal consultation. | | | | Read More | | |
| |
| | | | The purpose of the roundtable is to collaboratively identify, clarify, and solve common challenges related to clinical research, and foster a broader, consistent relationship and understanding where academia and industry interface. This year's event features two panels of speakers from the FDA, NIH, the All of Us research program, PCORI, and industry - one on the implementation of the 21st Century Cures Act and one on the future challenges of industry-funded research. | | | | Read More | | |
| |
| | | | Bench to Business, A Commercialization Workshop Series presented by Georgia Bio. A practical, hands-on workshop series focused on the challenge of commercializing bioscience technologies. | | | | Read More | | |
| |
| | | | The award is designed to stimulate businesses to pursue novel therapies for cystic fibrosis by filling the gap between basic research and Phase 3 clinical trials. | | | | Read More | | |
| |
| | | | | by Sherry Edwards, CCRC
Have you ever considered participating in medical research but thought “I am healthy; clinical research is for people who are ill” – not true! Healthy people contribute to medical advances by providing information about the “normal” state of health. In clinical research, healthy individuals participate as controls or “the norm” to compare with the condition under investigation. Research ... | | | | Read More | | |
|
| |
| | | | The event is coordinated by Portal de Salud with help from a broad range of volunteer organizations and provides free health services to attendees and helps coordinate Primary Care homes for patients. Stations at the event will include women's health, HIV, vision, hearing, exercise, health education, and children's services. Volunteers needed - Spanish language skills are not required to volunteer. | | | | Read More | | |
| |
| | | | This day will highlight Morehouse School of Medicine¿s (MSM) partnerships and collaborations with neighborhood residents and other external partners in service, research, patient care, and training. This day will be a time to celebrate, recognize, and support MSM's community partners for the unique roles they play in creating opportunities for better health where we live, learn, work and play. | | | | Read More | | |
| |
| | | | The RCMI Translational Science 2017 conference (October 28-November 1) will highlight the importance of basic, clinical, and population science collaborations to address minority health and health disparities. RCMI 2017 presents opportunities to share new and innovative approaches toward eliminating health disparities, developing the next generation of biomedical scientists, and extending the reach and visibility of the RCMI community by engaging NIMHD and NIH grantees with research interests in health disparities. | | | | Read More | | |
| |
| | | | Leading public health, law enforcement, and clinical experts discuss this national crisis ¿ from its causes to implications for our country's future. Event is free and open to the public. | | | | Read More | | |
| |
| | | | Presented by Jeffrey Skolnick, PhD, director, Center for the Study of Systems Biology, Mary and Maisie Gibson Chair and GRA Eminent Scholar in Computational Systems Biology, School of Biological Sciences,Georgia Institute of Technology and hosted by Morehouse School of Medicine in Hugh Gloster Building Room 205.
| | | | Read More | | |
| |
| | | | | The K-Club provides an educational forum to assist fellows and faculty. Facilitated by Stacy Heilman, PhD, Assistant Professor, Director, Pediatric Research Operations, Emory University Department of Pediatrics & Children’s Healthcare of Atlanta and presented by Lakshmanan Krishnamurti, MD, Assistant Professor, Director, Pediatric Research Operations, Emory University Department of Pediatrics & Children’s Healthcare of Atlanta.
A light ... | | | | Read More | | |
|
| |
| | | | The IEEE-EMBS Summer Meeting features Helen Mayberg, MD, professor of Psychiatry, Neurology, and Radiology and the Dorothy Fuqua Chair in Psychiatric Imaging and Therapeutics, Emory University School of Medicine. | | | | Read More | | |
| |
| | |
To improve human health, scientific discoveries must be translated into practical applications. Such discoveries typically begin at "the bench" with basic research, in which scientists study disease at a molecular or cellular level and then progress to the clinical level, or the patient's bedside. The conference will include state-of-the-art topics in clinical and translational science as well as opportunities for attendees to showcase their research ... | | | | Read More | | |
| |
| | | | The goal of this workshop is to address challenges and opportunities for impactful clinical trials in medical rehabilitation, such as trial design, issues in recruitment and retention, mobile technology integration, multi-modal interventions, control groups, response heterogeneity, rigor and reproducibility, and data and safety monitoring. Following an introductory lecture, workshop participants will divide into breakout sessions based on their experience level as investigators. Registration is free but space is limited. Travel award opportunities available. | | | | Read More | | |
| |
| | | | Presented by Shannon L. Gourley, PhD, assistant professor, Department of Pediatrics
Emory University School of Medicine, Yerkes National Primate Research Center and William Sharp, PhD, director, Pediatric Feeding Disorders Program, Marcus Autism Center, Children's Healthcare of Atlanta, Assistant Professor, Department of Pediatrics, Emory University School of Medicine.
| | | | Read More | | |
| |
| | | | | Presented by David Nash, MD, MBA, Dean, Jefferson College of Public Health, Thomas Jefferson University. Hosted by Emory-Georgia Tech Healthcare Innovation Program and the Georgia CTSA from noon to 2:00 p.m. in Emory School of Medicine auditorium 120. ... | | | | Read More | | |
|
| |
| | | | Join PCORI for this important event, which will bring together more than 1,000 researchers, patients, clinicians, and others from across the healthcare community. The theme of this year's meeting reflects the growing number of important findings being generated by PCORI-funded studies. | | | | Read More | | |
| |
| For more information on ACTSI, please visit
www.actsi.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
actsi@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
actsi@emory.edu.
Please include the following citation in any publications resulting from direct or indirect ACTSI support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2 TR000455 and TL1 Trainees should also list TL1 TR000456. |
| |
|
